Yang et al. [148] showed that GDH activity is upregulated in SF188 glioblastoma cells grown under conditions of impaired glycolysis and that inhibition of GDH by EGCG enhances the sensitivity of these cells to drugs that target glucose metabolism. This evidence concerns the gene GLUD1 and glioblastoma.